Significant Customers and Concentrations of Risk

9 Months Ended

Sep. 30, 2017

Risks And Uncertainties [Abstract]

Significant Customers and Concentrations of Risk

6. Significant Customers and Concentrations of Risk

Revenues by customer location are summarized as follows: 

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2017		2016		2017		2016
United States of America	$	14,174,112	$	12,036,590	$	37,009,301	$	33,631,332
Europe		750,470		1,215,218		3,018,099		3,829,809
Other		127,815		226,955		448,615		564,784
	$	15,052,397	$	13,478,763	$	40,476,015	$	38,025,925

Significant customers from which the Company derived 10% or more of its total revenue in any of the periods presented are as follows:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2017		2016		2017		2016
Teva	$	7,663,701	$	5,522,996	$	17,043,954	$	18,513,972
AMAG		1,767,702		2,369,950		6,338,275		3,275,832
McKesson		2,339,238		1,946,261		6,333,080		5,501,810
AmerisourceBergen		1,470,268		1,156,566		4,323,013		3,658,453
Ferring		723,502		1,246,300		3,018,098		3,960,689